Literature DB >> 14287601

SPECIFICITY OF MACROGLOBULIN ANTIBODY SYNTHESIZED BY THE NORMAL HUMAN FETUS.

W V EPSTEIN.   

Abstract

The umbilical cord blood of 47 out of 54 normal human infants contains hemagglutinating activity directed toward cells coated with a type-L Bence-Jones protein. This hemagglutinating material, in some instances, is present in cord blood in the absence of such activity in the maternal blood. Ultracentrifugation of cord serum in a sucrose gradient shows that the activity is associated with the macroglobulin fractions.

Entities:  

Keywords:  ANTIBODY FORMATION; BENCE JONES PROTEIN; FETUS; HEMAGGLUTINATION; MACROGLOBULINS; PHYSIOLOGY; PREGNANCY; ULTRACENTRIFUGATION; UMBILICAL CORD

Mesh:

Substances:

Year:  1965        PMID: 14287601     DOI: 10.1126/science.148.3677.1591

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  6 in total

1.  Lymphocytes with membrane-bound immunoglobulin (B-lymphocytes) in new-born babies.

Authors:  S S Fröland; J B Natvig
Journal:  Clin Exp Immunol       Date:  1972-08       Impact factor: 4.330

2.  Naturally-occurring macroglobulin antibody of foetal origin in the normal human newborn.

Authors:  W V Epstein; S W Fong; M Tan
Journal:  Immunology       Date:  1966-03       Impact factor: 7.397

3.  Distribution of malarial antibody in maternal and cord sera.

Authors:  A I Williams; H McFarlane
Journal:  Arch Dis Child       Date:  1969-08       Impact factor: 3.791

4.  Anti-IgG agglutinins in idiopathic respiratory distress syndrome of the newborn.

Authors:  G Hardie; J E Kench
Journal:  Arch Dis Child       Date:  1969-12       Impact factor: 3.791

Review 5.  Immunological diseases and pregnancy.

Authors:  J S Scott
Journal:  Br Med J       Date:  1966-06-25

6.  Shared idiotypic determinants on B and T lymphocytes reactive against the same antigenic determinants. II. Determination of frequency and characteristics of idiotypic T and B lymphocytes in normal rats using direct visualization.

Authors:  H Binz; H Wigzell
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.